发明名称 GLYCINE TRANSPORTER INHIBITOR
摘要 <p>The present invention provides a novel compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which is useful for prophylaxis or treatment of diseases such as schizophrenia, Alzheimer's disease, cognitive impairment, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post-traumatic stress disorder, a specific phobia, acute stress disorder and the like), depression, drug dependence, convulsion, tremor, pain, Parkinson's disease, attention deficit hyperactivity disorder, bipolar disorder, eating disorder and sleep disorder, on the basis of an inhibitory activity on glycine uptake.</p>
申请公布号 WO2013187503(A1) 申请公布日期 2013.12.19
申请号 WO2013JP66472 申请日期 2013.06.14
申请人 TAISHO PHARMACEUTICAL CO., LTD. 发明人 MORIYA, MINORU;YAMAMOTO, SHUJI;ABE, KUMI;OHTA, HIROSHI;SUN, XIANG-MIN;WAKASUGI, DAISUKE;ARAKI, YUKO
分类号 C07D233/70;A61K31/4164;A61K31/4439;A61K31/506;A61P1/00;A61P25/04;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/28;A61P25/30;A61P43/00;C07D401/04;C07D401/14;C07D403/04 主分类号 C07D233/70
代理机构 代理人
主权项
地址